showed a trendp = 0.07
Similarly, patients with a large lymph node burden as compared to primary tumor burden also showed a trend toward decreased survival (pre-treatment HR 4.52, 95% CI [1.43–14.33], p = 0.07; post-treatment HR 5.48, 95% CI [1.70–17.62], p = 0.06).